Feedback / Questions
rinzimetostat (ORIC-944) - ORIC Pharma
enozertinib (ORIC-114) - ORIC Pharma, Voronoi
https://www.globenewswire.com/news-release/2026/01/12/3216908/0/en/ORIC-Pharmaceuticals-Provides-Operational-Highlights-for-2025-and-Anticipated-Upcoming-Milestones.html
Jan 12, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next